[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339506-105":59,"doc-detail-339506-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","precision-oncology-artificial-intelligence-and-novel-therapeutic-advancements-highlights-from-the-59th-iacr-annual-conference","Precision Oncology, Artificial Intelligence, and Novel Therapeutic Advancements in the Diagnosis, Prevention, and Treatment of Cancer - Highlights from the 59th Irish Association for Cancer Research (IACR) Annual Conference","","Advancements in oncology, driven by precision oncology, are reshaping cancer care through a major paradigm shift. Artificial intelligence and data-science approaches are enabling improved diagnosis, prevention, individualized treatment, and new therapeutic discoveries, even as resistant cancers limit progress. By integrating biological mechanism understanding with AI-enabled technology, cancer researchers are advancing molecular interventions that support prevention, guide clinical decisions, and accelerate development of novel therapies. This conference report covers AI and precision oncology advances presented at the 59th IACR annual conference.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/precision-oncology-artificial-intelligence-and-novel-therapeutic-advancements-highlights-from-the-59th-iacr-annual-conference/339506/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/precision-oncology-artificial-intelligence-and-novel-therapeutic-advancements-highlights-from-the-59th-iacr-annual-conference/339506.png","ImageObject",300,407,{"name":92,"@type":93},"Violet","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main focus of the 59th IACR annual conference report?","Question",{"text":112,"@type":113},"The report highlights advances in precision oncology, including artificial intelligence and data science approaches, and how they support cancer diagnosis, prevention, and personalized treatment.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which major problem continues to challenge progress in cancer care?",{"text":117,"@type":113},"Resistant cancers constrain the pace and extent of advancement, limiting what can be achieved with current approaches.",{"name":119,"@type":110,"acceptedAnswer":120},"How do AI and data science contribute to precision oncology according to the text?",{"text":121,"@type":113},"They help enable enhanced diagnosis and prevention and support personalized interventions, including molecular approaches that inform clinical decisions and accelerate novel drug development.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},339506,1790158900,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},4398048950312,"https://ap-avatar.wpscdn.com/avatar/400002538284de19e3c?_k=1778320343897328908","cancers   \nConference Report  \nPrecision Oncology, Artificial Intelligence, and Novel Therapeutic Advancements in the Diagnosis, Prevention, and Treatment of Cancer: Highlights from the 59th Irish Association for Cancer Research (IACR) Annual Conference  \nSeodhna M. Lynch 1, Aisling B. Heeran 2, Caoimbhe Burke 3, Niamh Lynam-Lennon 2, Alex J. Eustace 4, Kellie Dean 5, Tracy Robson 6,*, Arman Rahman 7,† and Simone Marcone 2,†  \nCitation: Lynch, S.M.; Heeran, A.B.; Burke, C.; Lynam-Lennon, N.; Eustace, A.J.; Dean, K.; Robson, T.; Rahman, A.; Marcone, S. Precision Oncology, Artificial Intelligence, and Novel Therapeutic Advancements in the Diagnosis, Prevention, and Treatment of Cancer: Highlights from the 59th Irish Association for Cancer Research (IACR) Annual Conference. Cancers 2024, 16, 1989. [https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.3390/cancers16111989](10.3390/cancers16111989)  \nReceived: 19 April 2024  \nRevised: 21 May 2024  \nAccepted: 21 May 2024  \nPublished: 23 May 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Personalised Medicine Centre, School of Medicine, Ulster University, C-TRIC Building, Altnagelvin Area Hospital, Glenshane Road, Londonderry BT47 6SB, UK; [s.lynch1@ulster.ac.uk](s.lynch1@ulster.ac.uk)  \n2 Department of Surgery, Trinity Translational Medicine Institute, Trinity St. James’s Cancer Institute,  \nTrinity College Dublin, D02 PN40 Dublin, Ireland; [heerana@tcd.ie](heerana@tcd.ie) (A.B.H.); [lynamlen@tcd.ie](lynamlen@tcd.ie) (N.L.-L.);  \n[marcones@tcd.ie](marcones@tcd.ie) (S.M.)  \n3 UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Belfield, D04 C1P1 Dublin, Ireland; caoimbhe.burke@ucdconnect.ie  \n4 Life Sciences Institute, Dublin City University, D09 NR58 Dublin, Ireland; [alex.eustace@dcu.ie](alex.eustace@dcu.ie)  \n5 School of Biochemistry and Cell Biology, Western Gateway Building, University College Cork, T12 XF62 Cork, Ireland; [k.dean@ucc.ie](k.dean@ucc.ie)  \n6 School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, D02 YN77 Dublin, Ireland  \n7 UCD School of Medicine, UCD Conway Institute, University College Dublin, Belfield, D04 C1P1 Dublin, Ireland; [arman.rahman@ucd.ie](arman.rahman@ucd.ie)  \n* Correspondence: [tracyrobson@rcsi.ie](tracyrobson@rcsi.ie); Tel.: +353-(0)-1-402-2582 † These authors contributed equally to this work.  \nSimple Summary: The Irish Association for Cancer Research (IACR) held its 59th annual conference from Wednesday, 22nd of February, to Friday, 24th February 2023, in Athlone, Ireland. The following article is a report of knowledge conveyed at the conference. The main themes of this conference explored key areas of basic, clinical, and translational research, which impact the diagnosis and treatment of cancer patients. The research presented at the conference emphasised the continuously changing paradigm within cancer research, with sessions covering a wide spectrum of topics from personalised prevention to personalised intervention, alongside emerging hallmarks, novel drug discoveries, and delivery systems. This was in conjunction with advancements in applications of artificial intelligence and data science within precision oncology that will ultimately revolutionise healthcare for cancer patients.  \nAbstract: Advancements in oncology, especially with the era of precision oncology, is resulting ina paradigm shift in cancer care. Indeed, innovative technologies, such as artificial intelligence, are paving the way towards enhanced diagnosis, prevention, and personalised treatments as well as novel drug discoveries. Despite excellent progress, the em","cbCaihf2YRfJBATu","https://ap.wps.com/l/cbCaihf2YRfJBATu","pdf",705244,21,"English","# Introduction\n## Cancer burden and epidemiology\n## Economic impact of cancer\n# Conference focus and themes\n## Personalized prevention and intervention\n## Emerging hallmarks and novel drugs\n## Delivery systems and AI/data science","[{\"question\":\"What is the main focus of the 59th IACR annual conference report?\",\"answer\":\"The report highlights advances in precision oncology, including artificial intelligence and data science approaches, and how they support cancer diagnosis, prevention, and personalized treatment.\"},{\"question\":\"Which major problem continues to challenge progress in cancer care?\",\"answer\":\"Resistant cancers constrain the pace and extent of advancement, limiting what can be achieved with current approaches.\"},{\"question\":\"How do AI and data science contribute to precision oncology according to the text?\",\"answer\":\"They help enable enhanced diagnosis and prevention and support personalized interventions, including molecular approaches that inform clinical decisions and accelerate novel drug development.\"}]","Precision Oncology, Artificial Intelligence, and Novel Therapeutic Advancements in the Diagnosis, Prevention, and Treatment of Cancer - Highlights from the 59th Irish Association for Cancer Research (IACR) Annual Conference | PDF",1790030657,53,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ee66e381e5411ea547f46c9dcad98bbc.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2f015fa87df2622166ba6250cecabc38.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7e32d0271a3379c81b42f05a32041096.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7d7c67c03e42a392e63f58df06430f08.webp",980,1385]